Cargando…

Fixed dose drug combinations: Issues and challenges in India

Detalles Bibliográficos
Autores principales:	Gupta, Yogendra Kumar, Ramachandran, Suganthi S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980918/ https://www.ncbi.nlm.nih.gov/pubmed/27756941 http://dx.doi.org/10.4103/0253-7613.186200

Ejemplares similares

Treating Tuberculosis: Time to Introduce Fixed-Dose Drug Combinations
por: Manikandan, S
Publicado: (2012)

Fixed dose combinations in diabetes: Indian innovation, Indian pride
por: Kalra, Sanjay, et al.
Publicado: (2012)

Irrational fixed dose combinations of psychotropic drugs in India: Cause of concern
por: Solanki, Madhusudan Singh, et al.
Publicado: (2016)

Difference in described indications of medicines among drug information sources in India: An issue urgently to be addressed
por: Singh, Harmanjit, et al.
Publicado: (2016)

Issues in the management of drug resistant tuberculosis in India
por: Behera, D.
Publicado: (2013)

Triple fixed drug combinations in type 2 diabetes
por: John, Mathew, et al.
Publicado: (2015)

Fixed drug combination in hypertension and hyperlipidaemia in the developing world
por: Seedat, YK
Publicado: (2008)

A study of use of fixed dose combinations in Ahmedabad, India
por: Balat, Jayeshbhai Dineshchandra, et al.
Publicado: (2014)

Too bad! Fixed dose combination antiretroviral drugs
por: Agyarko-Poku, Thomas, et al.
Publicado: (2014)

Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
por: Webster, Ruth, et al.
Publicado: (2020)

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
por: Anvikar, Anupkumar R, et al.
Publicado: (2012)

India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
por: Sulis, Giorgia, et al.
Publicado: (2022)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India
por: Deolekar, Pradnya, et al.
Publicado: (2023)

Editorial for Special Issue—“Early-Stage Drug Discovery: Advances and Challenges”
por: Sippl, Wolfgang
Publicado: (2023)

Tuberculosis and COVID-19 in India: Challenges and opportunities
por: Prasad, Rajendra, et al.
Publicado: (2020)

A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report
por: Sarkar, Manuj K, et al.
Publicado: (2023)

Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
por: Canbakan, Başol
Publicado: (2013)

Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis
por: Gallardo, Carmen R, et al.
Publicado: (2016)

Child labour issues and challenges
por: Srivastava, Kalpana
Publicado: (2011)

Cancer metastasis: issues and challenges
por: Qian, Chao-Nan, et al.
Publicado: (2017)

Disability and Rehabilitation Services in India: Issues and Challenges
por: Kumar, S. Ganesh, et al.
Publicado: (2012)

Cancer research in India: Challenges & opportunities
por: Singh, Mayank, et al.
Publicado: (2018)

The renaissance of fixed dose combinations: Combivir
por: Portsmouth, Simon D, et al.
Publicado: (2007)

Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination
por: Fuwa, Masahiro, et al.
Publicado: (2016)

Special Issue “Hybrid Drugs: Design and Applications”
por: Singh, Parvesh, et al.
Publicado: (2023)

Fixed Dose Versus Loose Dose: Analgesic Combinations
por: Pergolizzi, Joseph, et al.
Publicado: (2023)

Prescription pattern of antiepileptic drugs in a tertiary care center of India
por: Joshi, Rupa, et al.
Publicado: (2020)

Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
por: Brhlikova, Petra, et al.
Publicado: (2023)

Ethics committee: Critical issues and challenges
por: Desai, Mira
Publicado: (2012)

Challenging issues in ocular adnexal disorders
por: Tsai, Chieh-Chih
Publicado: (2018)

Challenging issues in rheumatology: thoughts and perspectives
por: Lim, Nathan, et al.
Publicado: (2021)

The bioequivalence of fixed‐dose combination tablets of bisoprolol and ramipril and its drug‐drug interaction potential
por: Sus, Jan, et al.
Publicado: (2021)

Ethical issues in psychiatry research: Special concerns for India
por: Rao, T. S. Sathyanarayana, et al.
Publicado: (2013)

World Hypertension Day: Contemporary issues faced in India
por: Jose, Arun Pulikkottil, et al.
Publicado: (2019)

Treatment outcomes and associated factors among patients with drug-sensitive tuberculosis on daily fixed-dose combination drugs: A cohort study from Ahmedabad, India
por: Prajapati, Arpit C., et al.
Publicado: (2023)

Pharmacology education in India: Challenges ahead
por: Badyal, Dinesh Kumar
Publicado: (2016)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Fixed-dose combinations: An essential for rational preparation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Special Issue ‘Microbial glycobiotechnology’
por: Pandey, Ashok, et al.
Publicado: (2022)

Special Issue “Anticancer Drugs”
por: Meegan, Mary J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vdp7m9se64sd0nrlpivrjn9phd